Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:51 pm Sale | 13G | UNIQURE N V QURE | Nantahala Capital Management LLC | 3,158,027 6.6% | -729,912 (-18.77%) | View |
2024-02-13 4:33 pm Purchase | 13G | UNIQURE N V QURE | Vestal Point Capital LP | 3,925,000 8.2% | 3,925,000 (New Position) | View |
2024-02-09 10:05 am Sale | 13G | UNIQURE N V QURE | FMR LLC | 48,782 0.102% | -2,652,145 (-98.19%) | View |
2024-01-25 09:31 am Purchase | 13G | UNIQURE N V QURE | STATE STREET CORP STT | 3,478,872 7.28% | 760,996 (+28.00%) | View |
2023-10-06 2:34 pm Sale | 13G | UNIQURE N V QURE | BlackRock Inc. BLK | 1,731,216 3.6% | -3,246,954 (-65.22%) | View |
2023-02-14 4:54 pm Sale | 13G | UNIQURE N V QURE | Nantahala Capital Management LLC | 3,887,939 8.3% | -581,274 (-13.01%) | View |
2023-02-14 4:17 pm Sale | 13G | UNIQURE N V QURE | Point72 Asset Management L.P. | 1,745,461 3.7% | -1,866,230 (-51.67%) | View |
2023-02-14 4:06 pm Sale | 13G | UNIQURE N V QURE | PFM Health Sciences LP | 2,302,314 4.9% | -90,997 (-3.80%) | View |
2023-02-09 12:39 pm Sale | 13G | UNIQURE N V QURE | FMR LLC | 2,700,927 5.769% | -1,639,136 (-37.77%) | View |
2023-02-08 4:34 pm Sale | 13G | UNIQURE N V QURE | Invesco Ltd. IVZ | 219,506 0.5% | -2,154,729 (-90.75%) | View |
2023-02-03 4:34 pm Purchase | 13G | UNIQURE N V QURE | STATE STREET CORP STT | 2,717,876 5.81% | 2,717,876 (New Position) | View |
2023-01-23 3:52 pm Purchase | 13G | UNIQURE N V QURE | BlackRock Inc. BLK | 4,978,170 10.6% | 79,530 (+1.62%) | View |
2022-10-07 2:58 pm Purchase | 13G | UNIQURE N V QURE | BlackRock Inc. BLK | 4,898,640 10.5% | 604,835 (+14.09%) | View |
2022-09-26 4:16 pm Sale | 13G | UNIQURE N V QURE | Coller International Partners V A LP | 0 0% | -2,840,365 (Position Closed) | View |
2022-07-18 4:11 pm Purchase | 13G | UNIQURE N V QURE | PFM Health Sciences LP | 2,393,311 5.1% | 2,393,311 (New Position) | View |
2022-02-14 08:27 am Purchase | 13G | UNIQURE N V QURE | Nantahala Capital Management LLC | 4,469,213 9.7% | 1,720,174 (+62.57%) | View |
2022-02-11 5:05 pm Purchase | 13G | UNIQURE N V QURE | Point72 Asset Management L.P. | 3,611,691 7.8% | 3,143,854 (+672.00%) | View |
2022-02-11 09:26 am Sale | 13G | UNIQURE N V QURE | ForUniqure B.V. | 546,166 1.29% | -3,840,576 (-87.55%) | View |
2022-02-10 11:32 am Sale | 13G | UNIQURE N V QURE | Invesco Ltd. IVZ | 2,374,235 5.1% | -1,056,658 (-30.80%) | View |
2022-02-09 10:01 am Sale | 13G | UNIQURE N V QURE | FMR LLC | 4,340,063 9.391% | -109,546 (-2.46%) | View |